Solentim

clarity in cell line development commercial stable cell line development for biopharmaceutical production and gene therapy is a high value process which is inherently expensive and takes a significant amount of time. solentim® has established itself over the past seven years as a significant leader and innovator of new products in the cell line development arena. our cell metric® product range of bright field imaging stations has a large global installed base of customers, and we are recognised as a leader for documenting proof of clonal origin for master cell banks in filings to the regulators. we have most recently introduced a second-generation single cell printing system called vips™, for customers that are looking for a simpler, more reliable alternative to facs and limiting dilution